|
Volumn 38, Issue 3, 2001, Pages 610-618
|
Systemic adenosine given after ischemia protects renal function via A2a adenosine receptor activation
|
Author keywords
Acute renal failure; Dibutyryl cyclic adenosine monophosphate (cAMP); Ischemic reperfusion injury; Kidney
|
Indexed keywords
1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER;
2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE);
8 (3 CHLOROSTYRYL)CAFFEINE;
8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE;
ADENOSINE;
ADENOSINE A1 RECEPTOR AGONIST;
ADENOSINE A1 RECEPTOR ANTAGONIST;
ADENOSINE A2A RECEPTOR;
ADENOSINE A2A RECEPTOR AGONIST;
ADENOSINE A2A RECEPTOR ANTAGONIST;
ADENOSINE A3 RECEPTOR;
ADENOSINE A3 RECEPTOR AGONIST;
ADENOSINE A3 RECEPTOR ANTAGONIST;
ADENOSINE RECEPTOR BLOCKING AGENT;
ADENOSINE RECEPTOR STIMULATING AGENT;
BUCLADESINE;
CREATININE;
CYCLIC AMP;
N6 (3 IODOBENZYL) N METHYL 5' CARBAMOYLADENOSINE;
PHENYLISOPROPYLADENOSINE;
UNCLASSIFIED DRUG;
ACUTE KIDNEY FAILURE;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MECHANISM;
HISTOPATHOLOGY;
KIDNEY FUNCTION;
KIDNEY ISCHEMIA;
MALE;
NONHUMAN;
PHARMACOLOGICAL BLOCKING;
PHARMACOLOGICAL STIMULATION;
RAT;
RECEPTOR BLOCKING;
RECEPTOR UPREGULATION;
REPERFUSION INJURY;
SECOND MESSENGER;
|
EID: 0034874636
PISSN: 02726386
EISSN: None
Source Type: Journal
DOI: 10.1053/ajkd.2001.26888 Document Type: Article |
Times cited : (56)
|
References (47)
|